Hari S. Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hari S. Sharma has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A.J.J. C. Bogers
Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication- Cang-Bao Xu
Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, China
1 shared publication David Erlinge
University Hospital
1 shared publicationDirk Weisensee
Center for Internal Medicine J. W. Goethe University Hospital Frankfurt am Main, Germany
1 shared publicationE. Yilmaz
Pharmacology, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publicationIris Löw-Friedrich
Center for Internal Medicine J. W. Goethe University Hospital Frankfurt am Main, Germany
1 shared publication
Latest Publications
- 1 January 2002
- Published by Springer Nature
- p. 197-212
Molecular Phenotype of the Developing Heart with a Congenital Anomaly
- 1 January 2002
- Published by Springer Nature
- p. 197-212
Molecular Phenotype of the Developing Heart with a Congenital Anomaly
- Open Access
- 28 November 2001
- Published by Springer Nature in Respiratory Research
- Vol. 3 (1) , 11
Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle
Chronic airway inflammation is one of the main features of asthma. Release of mediators from infiltrating inflammatory cells in the airway mucosa has been proposed to contribute directly or indirectly to changes in airway structure and function. The airway smooth muscle, which has been regarded as a contractile component of the airways responding to various mediators and neurotransmitters, has recently been recognised as a rich source of pro-inflammatory cytokines, chemokines and growth factors. In this review, we discuss the role of airway smooth muscle cells in the regulation and perpetuation of airway inflammation that contribute to the pathogenesis of asthma.
- 28 November 2001
- Published by Springer Nature in Respiratory Research
- Vol. 3 (1) , 11
Open AccessAutocrine regulation of asthmatic airway inflammation: role of airway smooth muscle
Chronic airway inflammation is one of the main features of asthma. Release of mediators from infiltrating inflammatory cells in the airway mucosa has been proposed to contribute directly or indirectly to changes in airway structure and function. The airway smooth muscle, which has been regarded as a contractile component of the airways responding to various mediators and neurotransmitters, has recently been recognised as a rich source of pro-inflammatory cytokines, chemokines and growth factors. In this review, we discuss the role of airway smooth muscle cells in the regulation and perpetuation of airway inflammation that contribute to the pathogenesis of asthma.
- 1 August 2001
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 224 (1-2) , 151-158
Endocardial expression and functional characterization of endothelin-1
Endothelin1 (ET1), a 21 amino acid peptide exerts a wide range of biological activities including vasoconstriction, mitogenesis and inotropic effects on the heart. In this study, we examined whether...
- 1 August 2001
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 224 (1-2) , 151-158
Endocardial expression and functional characterization of endothelin-1
Endothelin1 (ET1), a 21 amino acid peptide exerts a wide range of biological activities including vasoconstriction, mitogenesis and inotropic effects on the heart. In this study, we examined whether...
- 1 June 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 874 (1 HEART IN) , 278-285
Quantitative Analysis of Collagens and Fibronectin Expression in Human Right Ventricular Hypertrophya
One of the main features in human tetralogy of Fallot (TF) is right ventricular hypertrophy (RVH) due to pressure (sub-pulmonary stenosis) and volume overload (ventricular septal defect). Currently, primary correction at a young age is the treatment of choice. To unravel the role of extracellular matrix in RVH, we examined myocardial expression of collagens and fibronectin in TF patients with primary correction (TF1, age 0.7 +/- 0.2 yr.), secondary surgery (TF2, age 36.9 +/- 4.6 yr), and in age-matched control patients. Sirius red staining quantified by video imaging showed significantly increased interstitial staining for collagens in both TF1 and TF2 groups as compared to respective controls. Fibronectin was expressed in extracellular spaces, perivascular regions, and in some cardiomyocytes. Quantitative analysis of fibronectin revealed increased expression in only TF1 group as compared to respective control. Our results indicate an increased amount of myocardial extracellular matrix deposition as a sign of fibrosis during RVH in patients with TF.
- 1 June 1999
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 874 (1 HEART IN) , 278-285
Quantitative Analysis of Collagens and Fibronectin Expression in Human Right Ventricular Hypertrophya
One of the main features in human tetralogy of Fallot (TF) is right ventricular hypertrophy (RVH) due to pressure (sub-pulmonary stenosis) and volume overload (ventricular septal defect). Currently, primary correction at a young age is the treatment of choice. To unravel the role of extracellular matrix in RVH, we examined myocardial expression of collagens and fibronectin in TF patients with primary correction (TF1, age 0.7 +/- 0.2 yr.), secondary surgery (TF2, age 36.9 +/- 4.6 yr), and in age-matched control patients. Sirius red staining quantified by video imaging showed significantly increased interstitial staining for collagens in both TF1 and TF2 groups as compared to respective controls. Fibronectin was expressed in extracellular spaces, perivascular regions, and in some cardiomyocytes. Quantitative analysis of fibronectin revealed increased expression in only TF1 group as compared to respective control. Our results indicate an increased amount of myocardial extracellular matrix deposition as a sign of fibrosis during RVH in patients with TF.
- 1 September 1996
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 793 (1) , 267-281
Tumor Necrosis Factor-?-Induced Cytoprotective Mechanisms in Cardiomyocytes.
- 1 September 1996
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 793 (1) , 267-281
Tumor Necrosis Factor-?-Induced Cytoprotective Mechanisms in Cardiomyocytes.